ClinConnect ClinConnect Logo
Search / Trial NCT06576661

Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes

Launched by UNIVERSITY OF KANSAS MEDICAL CENTER · Aug 26, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Intrarenal Pressure Litho Vue Elite

ClinConnect Summary

This clinical trial is looking at how a special tool called the LithoVue Elite ureteroscope, which helps doctors treat kidney stones, can be improved by using a technology that measures pressure inside the kidney in real-time. The main goal is to see if having this pressure information helps surgeons make better decisions during the procedure and improves the results for patients afterward.

To participate in this trial, you need to be at least 18 years old and have kidney stones that are larger than 2 cm, located in the upper ureter or kidney. However, if you are undergoing treatment for kidney stones on both sides at the same time, have certain medical conditions, or are pregnant, you won’t be eligible. If you join the study, you can expect to undergo a flexible ureteroscopy, which is a procedure that helps remove stones, and your experience will help researchers understand how to make this treatment safer and more effective for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Males or females over 18 years of age
  • Undergoing flexible ureteroscopy to address urinary stones located in the proximal ureter or kidney
  • Total stone burden over 2 cm
  • Exclusion Criteria:
  • 1. Undergoing bilateral stone treatment during the same procedure
  • 2. Patients with known genitourinary anatomical abnormalities
  • 3. Uncorrected coagulopathy
  • 4. Patients with urinary diversions
  • 5. Chronic external urinary catheters
  • 6. Women who are pregnant
  • 7. Immunosuppressed patients

About University Of Kansas Medical Center

The University of Kansas Medical Center (KUMC) is a leading academic medical institution dedicated to advancing healthcare through innovative research, education, and clinical practice. As a prominent clinical trial sponsor, KUMC leverages its extensive expertise in diverse medical fields to conduct rigorous clinical research aimed at improving patient outcomes and developing new treatment modalities. With a commitment to ethical standards and patient safety, KUMC collaborates with multidisciplinary teams to facilitate groundbreaking studies that address significant health challenges, ultimately contributing to the advancement of medical knowledge and the enhancement of community health.

Locations

Kansas City, Kansas, United States

Patients applied

0 patients applied

Trial Officials

Bristol B Whiles, MD

Principal Investigator

University of Kansas Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported